Signant Health appoints Sanjiv Waghmare as Chief Product Officer

Waghmare will be responsible for building upon the success of Signant’s clinical research science and technology solutions

Signant Health announced the appointment of Sanjiv Waghmare as Chief Product Officer. Waghmare will be responsible for building upon the success of Signant’s pioneering clinical research science and technology solutions with an emphasis on steering roadmap strategy and optimising core solutions to support the exponential growth of virtual, remote, decentralised, and hybrid clinical trials.

With his depth of understanding in product innovation and lifecycle management, Waghmare will play an integral role in positioning Signant’s solutions and services for ongoing success within a rapidly- evolving clinical research environment as well as driving next-generation advancements in data strategy, user experience, and configurability of the company’s core platforms.

“I am truly honoured to join Signant Health as the company’s Chief Product Officer,” said Waghmare of his new role. “Signant is a clear leader at delivering software and services that support evidence generation across patients, sites, and clinical supply management. I look forward to continuing to drive that vision with a holistic approach to product development that will serve customers across traditional and decentralised trials.”

Waghmare joins Signant Health from Wolters Kluwer, a leading provider of software, research, and learning solutions for tax, accounting, and audit professionals, where he was Head of Product Management, responsible for developing and managing innovative products for the tax and audit industries. Before Wolters Kluwer, he led product management teams at Intuit, Finastra and Capital One, and was a business strategy consultant at McKinsey & Company.

Commenting on his appointment, CEO Roger Smith said, “Waghmare has an exceptional track record leading and implementing innovative product solutions within complex and competitive financial technology industries. His leadership and deep understanding of product management processes will allow our product teams to create a solution portfolio that reflects our mission to become the pre-eminent enabler of direct-from-patient evidence generation.”